Lonza Group Ltd (LZAGF) 117.7000 $LZAGF
Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 with Abbott Laboratories, Aurobindo Pharma, Mylan & Teva Pharmaceutical Industries Dominating
M2 - Mon Feb 09, 10:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/jgfvvc/active) has announced the addition of the "Active Pharmaceutical Ingredients (API) Market in the US 2015-2019" report to their offering. The API market in the US to grow at a CAGR of 7% over the period 2014-2019 Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis. One major trend upcoming in the market is the strong focus on the development and introduction of high-potency API. Such products are increasingly used in oncology and for the provision of targeted therapy. According to the report, one of the key drivers contributing to the growth of the API market in the US is the strong preference for generic drugs compared with innovative or branded drugs. The use of generic equivalents is preferred to innovative drugs, with countries encouraging doctors and pharmacists to prescribe such equivalents. Further, the report states that stringent regulationse one of the major challenges that the market faces. Vendors are required to comply with elaborate procedures prior to product commercialization. For instance, compliance with GMP requirements increases costs for vendors. Key Vendors - Abbott Laboratories - Aurobindo Pharma - Mylan - Teva Pharmaceutical Industries Other Prominent Vendors - Albemarle - Aptuit - BASF - Biocon - Boehringer Ingelheim - Cambrex - Cipla - Dr. Reddy's Laboratories - Hospira - Lonza Group - Novartis - Pfizer - Sigma-Aldrich - Sun Pharmaceutical Industries Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - API Market in the US - Market Segmentation by Type of Production Process - Market Segmentation by Type of Product - Market Segmentation by Type of Players - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/jgfvvc/active
ABT: 46.09 (+0.87), CBM: 32.96 (+0.09), TEVA: 56.77 (-0.58), NVS: 102.20 (-0.17)
Global L-carnitine Industry Market Report 2015
M2 - Wed Jan 28, 9:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/7bv6nf/global) has announced the addition of the "Global L-carnitine Industry Report 2015" report to their offering. The Global L-carnitine Industry Report 2015 is a professional and in-depth study on the current state of the L-carnitine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The L-carnitine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. L-carnitine industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on thirteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The L-carnitine industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 168 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Key Topics Covered: - L-carnitine Industry Overview - L-carnitine International and China Market Analysis - L-carnitine Technical Data and Manufacturing Plants Analysis 2014 - L-carnitine Production by Regions By Technology By Applications 2009-2015 - L-carnitine Manufacturing Process and Cost Structure - L-carnitine Productions Supply Sales Demand Market Status and Forecast 2009-2015 - L-carnitine Key Manufacturers Analysis - Up and Down Stream Industry Analysis - L-carnitine Marketing Channels Analysis - L-carnitine Productions Supply Sales Demand Market Status and Forecast 2015-2020 - L-carnitine Supply Chain Relationship Analysis - L-carnitine New Project Investment Feasibility Analysis - Global and China L-carnitine Industry Research Conclusion Companies Mentioned - AIDP (USA) - HuangGang HuaYang (China) - Hubei Hongjing (China) - Kaiyuan Hengtai (China) - Lonza Group (Switzerland) - NINGBO HONOR CHEMTECH (CHINA) - Northeast Pharmaceutical (China) - ShangHai KangXin (China) - Shenyang Koncepnutra (China) - Wuhan Saiguang (China) - Xinxiang Kangjian (China) - Yichang Yongnuo (China) - ZHEJIANG JIASHAN CHENGDA (CHINA) For more information visit http://www.researchandmarkets.com/research/7bv6nf/global
Water Treatment Chemicals Trends & Forecasts to 2019: Corrosion Inhibitor, Scale Inhibitor, Coagulants & Flocculants, Biocides & Disinfectants, Chelating Agents, Anti-foaming Agents, pH Adjusters & Stabilizers
M2 - Tue Jan 13, 10:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/c96mvk/water_treatment) has announced the addition of the "Water Treatment Chemicals Market By Type, By Application - Global Trends & Forecasts to 2019" report to their offering. The water treatment chemicals market is projected to grow at a CAGR of 5.8% between 2014 and 2019 to reach $33,289 million by 2019 in terms of value. Water treatment chemicals are chemical compounds used to remove the impurities from water. Use of water is ever increasing with the economic development and rapid urbanization in emerging countries. The industrial sector requires water for cooling, washing, and processing in different applications including power generation, steel, chemicals, pulp & paper, and petroleum refining. Water treatment chemicals are also used to treat municipal water.. In the recent years, water treatment chemicals have been used in the treatment of agricultural wastewater. The increasing population and industrial activities are driving the demand for clean and fresh water. The consumption of water treatment chemicals depends on the source of water; which can be sea, ground, or municipal drinking water. The quality of water depends on various defined parameters such as TDS (Total Dissolved Solids), hardness, pH, and alkalinity. The demand is also influenced by different such as water availability, its usage pattern, presence of pollutants, government policies, and trade-offs among various chemical compounds. Globally, the Asia-Pacific region dominated the water treatment chemicals market size in terms of both value and volume in 2013. China and India are the major countries with a huge demand for water treatment chemicals. Market players concentrate on expanding their market reach. Other development strategies adopted by market players are new product launches, agreements & collaborations, and mergers & acquisitions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Water Treatment Chemicals Market, By Product Type 8 Global Water Treatment Chemicals Market, By Application 9 Global Water Treatment Chemicals Market - By Region 10 Competitive Landscape 11 Company Profiles - Air Products And Chemicals, Inc. - Akzonobel Nv - Ashland Corporation - Basf Se - Buckman Laboratories International Inc. - Bwa Water Additives UK Limited - Cortec Corporation - Ecolab (Nalco Company) - Ge Water & Process Technologies - Kemira Oyj - Lonza Group LTD. - The Dow Chemical Ompany For more information visit http://www.researchandmarkets.com/research/c9..._treatment
APD: 152.81 (+0.59), ECL: 111.62 (+0.85)
Global Active Pharmaceutical Ingredients (API) Market Forecasts 2014-2020: Market Expected to Grow by 8% (Updated Edition)
M2 - Wed Jan 07, 2:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/55tnr3/active) has announced the addition of the "Active Pharmaceutical Ingredients (API) Global Market - Forecast to 2020" report to their offering. The global API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019 The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation. Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source. Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Global API Market Overview 5 Global API Market, By Therapeutic Application 6 Regional Market Analysis 7 Company Developments 8 Major Player Profiles - Albemarle Corporation - Aurobindo Pharma Limited - Boehringer Ingelheim Gmbh - Dr. Reddy'S Laboratories Limited - Fresenius Kabi - Lonza Group Ltd - Lupin Limited - Novartis International Ag - Ranbaxy Laboratories Limited - Sun Pharmaceuticals Industries Ltd - Teva Active Pharmaceutical Ingredients For more information visit http://www.researchandmarkets.com/research/55tnr3/active
ALB: 54.59 (+0.63), NVS: 102.20 (-0.17)
Animal Feed Additives - Global Strategic Business Report
M2 - Tue Dec 16, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/24vhpg/animal_feed) has announced the addition of the "Animal Feed Additives - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Animal Feed Additives in US$ Million by the following Product Segments: Antibiotics/Antibacterials, Vitamins, Antioxidants, Amino Acids, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 272 companies including many key and niche players such as: - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc. - Alltech Inc. - Archer Daniels Midland Company Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study - Product Definitions - Antibiotics/Antibacterials - Vitamins - Antioxidants - Amino Acids - Others II. EXECUTIVE SUMMARY 1. OUTLOOK 2. COMPETITIVE LANDSCAPE 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. REGULATORY & ENVIRONMENTAL ANALYSIS 6. PRODUCT INTRODUCTIONS/APPROVALS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT GLOBAL PLAYERS - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc - Ajinomoto Eurolysine S.A.S - Alltech Inc - Archer Daniels Midland Company - BASF SE - Biovet JSC - Cargill, Inc - Provimi Holding - Chr. Hansen - DSM Nutritional - DuPont - Elanco Animal Health - Evonik Industries AG (Germany) - InVivo NSA S.A. (France) - Kemin Industries, Inc. (US) - Lonza Group Ltd (Switzerland) - Novozymes A/S (Denmark) - Novus International, Inc. (US) - Nutreco N.V (the Netherlands) - Phibro Animal Health Corporation (US) - Tessenderlo Group (Belgium) - The Mosaic Company (US) - Zoetis, Inc. (US) 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. MIDDLE EAST/AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/24...nimal_feed
ZTS: 45.46 (-0.33), ADM: 48.10 (+0.66), PAHC: 30.85 (+0.36)
Global Cell Line Development (Equipment, Media and Reagents) Market Research Report 2014-2019
M2 - Mon Dec 01, 7:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/969944/cell_line) has announced the addition of the "Cell Line Development Market by Product, Source, Type & by Application - Analysis & Global Forecast to 2019" report to their offering. The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019 The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years. Over the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have led to growth in a number of applications of cell lines such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. Cell line development media and reagents account for the largest share in the global cell line development market, as they have numerous applications in areas such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. The reagents segment accounted for the maximum share of the cell line development media and reagents market. The bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and in manufacturing of recombinant protein therapeutics. North America accounted for the largest share of the global cell line development market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cell line development market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to serve as revenue pockets for cell line manufacturers. Scope of the Report - Product (Equipment, Media and Reagents) - Source - Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Cell Line Development Market, By Product 8 Cell Line Development Market, By Source 9 Cell Line Development Market, By Type 10 Global Cell Line Development Market, By Application 11 Cell Line Development Market, By Geography 12 Competitive Landscape 13 Company Profiles - American Type Culture Collection (ATCC) - Corning, Inc. - European Collection of Cell Cultures (ECACC) - GE Healthcare - Lonza Group AG - Sartorius AG - Selexis SA - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. - Wuxi Apptec For more information visit http://www.researchandmarkets.com/research/969944/cell_line
SIAL: 138.20 (+0.07)
Global Active Pharmaceutical Ingredients Market - Trends & Forecast to 2020 for the $190 Billion Industry
M2 - Thu Nov 20, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/sm7qx5/global_active) has announced the addition of the "Global Active Pharmaceutical Ingredients Market - Trends & Forecast to 2020" report to their offering. The global Active Pharmaceutical Ingredient market is expected to reach a market size approximately $190 billion by 2020, growing at a CAGR of more than 6.5% from 2014 to 2020 API market is mainly driven by the factors such as patent expiration of major drugs, increased generic medicine sales and high uptake of biologics. High Potential Active Pharmaceutical Ingredients (HPAPI) are also driving the API market growth globally as these compounds are very effective in treatment of diseases such as cancer, respiratory disorders and hormonal imbalances and HPAPI growth is mainly driven by its therapeutic applications in Oncology. Depending on the product type the API market is segmented into synthetic API, Biotech API, and HPAPI. Synthetic API commanded the largest share in 2013 and is growing at a steady pace, whereas the biotech API is expected to register the highest CAGR during the forecast period, strongly driven by the monoclonal antibodies and recombinant proteins. Depending on the applications the API market is categorized into oncology, cardiovascular and hematopoietic system, central nervous system, anti-infective, gastrointestinal, respiratory system, metabolic disorders, genito-urinary disorders, and others. Cardiovascular commanded the largest share of more than 40% in 2013 and is growing at a steady pace, whereas oncology is expected to register the highest CAGR during the forecast period. HPAPI commanded the largest share in the oncology application segment in 2013 and is growing at a highest CAGR in the anti-infectives segment. Scope of the Report Global API Market, by Synthesis: - Synthetic Chemical API - Branded/Innovative - Generic/Non-branded - Biotech API - Biologics - Biosimilars - Mammalian cell culture - Monoclonal antibodies - Recombinant proteins - Vaccines - Insulin analog - Growth hormone manufacturing - Interferon manufacturing - HPAPI Global API Market, by Business type: - Captive - Merchant Global API Market, by Therapeutic Applications: - Anti-infectives - Oncology - Cardiovascular and hematopoietic system - Central nervous system - Respiratory system - Gastrointestinal disorders - Hormone-related disorders - Metabolic disorders - Genitourinary disorders - Musculo-skeletal disorders - Others Companies Mentioned - Albemarle Corporation - Aurobindo - Boehringer Ingelheim GmbH - Cambrex Corporatio - Dr. Reddy's Lab - Lonza Group - Lupin - Novartis - Ranbaxy Laboratories - Teva Active Pharmaceutical Industries Limited For more information visit http://www.researchandmarkets.com/research/sm...bal_active
CBM: 32.96 (+0.09), ALB: 54.59 (+0.63), NVS: 102.20 (-0.17)
Global Gut and Digestive Health Ingredients and Consumer Products Market Trends and Insights 2013-2018
M2 - Fri Nov 07, 6:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/n2d9z7/gut_and_digestive) has announced the addition of Canadean Ltd's new report "Gut and Digestive Health Ingredients and Consumer Products - Market Trends and Insights" to their offering. Millions of consumers are facing gut and digestive health disorders which provides business opportunities for dietary supplement producers looking to provide effective products that can help manage illness and intolerances, as well as promote overall health. Global demand for probiotics is predicted to grow at a CAGR of 6.8% from 2013 to 2018. The gastrointestinal health supplement category saw $1.4 billion in consumer sales in 2011, a 14% percent increase over the previous year. The regulatory environment is difficult and the industry is daring flexible interpretations of the regulations in certain regions. Manufacturers will need to consult with local authorities before making a decision on how to represent probiotics or prebiotics on labels. However, a lack of understanding amongst the public regarding fiber importance in the diet, and how much fiber should be consumed on a daily basis, remains a communication hurdle for product manufacturers. Certain polyphenols seem to act as prebiotic-type substances and offers innovation opportunities for the industry. Additionally, some phenolic acids affect the expression and activity of enzymes involved in the production of inflammatory mediators thought to be important in the development of gut disorders, including colon cancer. Another prospect group of ingredients are dietary enzymes targeting a wide range of digestive health issues. As consumer awareness for this unique category of dietary supplements grows, companies could begin to combine enzymes with other nutrients that can enhance beneficial effects in the gut. It is expected that major industry participants such as Nestec SA (Switzerland), Alimentary Health Limited, and Nutrica NV will increase their R&D efforts to develop new products and new product applications, along with their approval in various geographic regions to gain a competitive edge. Universities and other small organizations and companies around the world also play a dynamic role in the development of the industry. Key Topics Covered: 1.Introduction 2. Executive Summary 3. Introduction to Gut and Digestive Health 4. Gut and Digestive Health Ingredients 5. Consumer Product Manufacturers 6. General Sources 7. Appendix Companies Mentioned - Beneo BV - Cargill Inc. - Chr Hansen Holdings A/S - Cosucra Group - Danone - Dupont Danisco A/S - Ganeden Biotech Inc. - General Mills - Gnosis SpA - Hipp Uk Limited - Kellogg's - Lesaffre Group - Liberte - Lonza Group Ltd - NZ Extracts Ltd - Natural Remedies Pvt Ltd - Nestle - Next Food - Parmalat - Planters - Roxlor LLC - Swanson etc. - Tate and Lyle - Vital solutions For more information visit http://www.researchandmarkets.com/research/n2..._digestive
GIS: 52.48 (-0.45)
Lonza Group Ltd. and CAMO Software AS have entered into agreement to deliver software solution.
M2 - Fri Nov 07, 6:28AM CST
Lonza Group Ltd. and CAMO Software AS have entered into an agreement to deliver a PAT software solution to the Lonza Visp site. The solution will be integrated with existing production systems at Lonza offering greater flexibility with minimal system duplication.
Global Polyether Polyols Market Research Report 2014-2019
M2 - Tue Nov 04, 10:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/pdtxkh/micro_market) has announced the addition of the "Micro Market Monitor : Global Polyether Polyols Market Research Report" report to their offering. Polyether Polyols and Polyester Polyols adds up to total Polymeric Polyols market. Polyether Polyols can be segmented by Geographies, Companies, Ingredients, Applications and Submarkets. Companies of this market are Dow Chemical, Bayer MaterialScience, BASF SE (Parent), Shell Chemicals Ltd, Huntsman Corporation, Carpenter Chemical, PERSTORP AB, Repsol, Rabigh, Dong Da Chemical Co, CPSC, Korea Polyol and Other Companies. Ingredients of this market are Propylene Oxide and Ethylene Oxide. Applications of this market are Electroactive Polymers, Polyurethane CASE, Polyurethane Flexible Foam and Polyurethane Rigid Foam. Submarkets of this market are Bio-Based Polyether Polyols and Petro-Based Polyether Polyols. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Polyether Polyols Market, By Application, 2014-2019 6 Global Polyether Polyols Market, By Geography 7 Company Profiles - Baalbaki Group S.A. - Basf Se - Bayer Ag - Biotor Industries Limited - Cargill Incorporated - Chemtura Corporation - Coim S.P.A - Expanded Polymer Systems Pvt. Ltd - Huntsman Corporation - Invista - Lonza Group Ltd - Manali Petrochemicals Ltd - Nanjing Hongbaoli Co. Ltd - Pcc Rokita Sa - Perstorp Ab - Royal Dutch Shell Plc - Royal Industries - Shandong Dongda Chemical Industry Co. Ltd - Shraddha Associates (Gujarat) Pvt. Ltd - Stepan Company - The Dow Chemical Company - Vertellus Specialties Inc. For more information visit http://www.researchandmarkets.com/research/pd...cro_market
CHMT: 24.77 (+0.81), DOW: 49.44 (+0.29), SCL: 41.23 (+0.34)
Fermentation Chemicals - 2014 Global Strategic Business Report
M2 - Thu Oct 23, 5:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7b995t/fermentation) has announced the addition of the "Fermentation Chemicals - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Fermentation Chemicals in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 86 companies including many key and niche players. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Analysis 2. Competition 3. Market Trends 4. Product Overview 5. End-Use Market Analysis 6. Product Innovations/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 86 (including Divisions/Subsidiaries - 100) - The United States (40) - Canada (1) - Japan (10) - Europe (34) - - France (9) - - Germany (
- - The United Kingdom (3) - - Italy (2) - - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (11) - Latin America (1) - Africa (1) - Middle East (2) Companies Featured: - AB Enzymes GmbH - Adisseo France S.A.S - Ajinomoto Company, Inc. - Amano Enzyme Inc. - Amino GmbH - Asahi Kasei Corporation - Archer Daniels Midland Company - Ashland, Inc. - BASF SE - Cargill, Inc. - Chr. Hansen A/S - Corbion NV - Dow Chemical Company - DuPont Nutrition and Health - Evonik Industries AG - Gadot Biochemical Industries Ltd. - Jungbunzlauer AG - Kyowa Hakko Bio Co. Ltd. - Lonza Group AG - MGP Ingredients, Inc. - Novozymes A/S - Novus Biologicals, LLC - Roquette Freres SA - Royal DSM - Tate & Lyle PLC - Wacker Chemie AG For more information visit http://www.researchandmarkets.com/research/7b...rmentation
ASH: 127.58 (+1.21), ADM: 48.10 (+0.66), MGPI: 14.00 (-0.39), DOW: 49.44 (+0.29)
U.S. Antimicrobial Plastics Market Outlook 2020
M2 - Tue Oct 14, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/23pc35/u_s) has announced the addition of the "U.S. Antimicrobial Plastics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The market for antimicrobial plastics has grown rapidly over the past few years. This trend is likely to continue in the near future. Research is being conducted to discover a new variety of plastic compounds in order to develop implants and biomedical devices with higher resistance to microbial adhesion and biofilm formation. A number of polymers have been developed that can be incorporated into cellulose and other materials. This would result in significant advances in various industries such as textiles, catheter tubes, food packaging, wound dressing and sterile surfaces. A greater need for materials that fight infection would act as an incentive for the discovery and usage of antimicrobial polymers. Healthcare was the largest segment, accounting for about 44% of the total U.S. antimicrobial plastics industry in 2013. This was followed by packaging and electronic & consumer appliances segments. This trend is anticipated to continue during the forecast period. The usage of antimicrobial plastics in healthcare applications helps prevent and control infection. Demand for antimicrobial plastics in the U.S. is estimated to increase significantly due to the implementation of stringent regulations regarding healthcare and hygiene. Furthermore, personal care packaging, including skin care and hair care products and cosmetics, coupled with packaging of pharmaceuticals and food & beverages is projected to boost demand for antimicrobial plastics during the forecast period. Antimicrobial plastics are governed by the Environmental Protection Agency (EPA) of the U.S. According to the EPA, plastics containing antimicrobials qualify as treated articles. Furthermore, antimicrobials are considered pesticides under the EPA. Due to this, antimicrobial plastics need to be registered with the EPA. There are several legislations in relation to antimicrobial plastics in medical devices. Most medical devices are governed by the EPA. However, antimicrobials that are intended to be released by the medical device are regulated by the FDA and classified as drugs. Application Segment Analysis - Electronics & consumer appliances - Personal care - Packaging - Automotive - Building & construction - Healthcare - Others (Includes sportswear, waste bins, etc.) Key players in the U.S. antimicrobial plastics market include - AkzoNobel - BASF - Bayer - The Dow Chemical Company - Lonza Group - Sherwin-Williams For more information visit http://www.researchandmarkets.com/research/23pc35/u_s
SHW: 285.00 (+1.98)
Research and Markets: Cell Line Development Market Outlook 2019: Key Players in the $3.9 Billion Industry are ATCC, Lonza Group, Thermo Fisher Scientific, GE, Sigma Aldrich, Selexis, ECACC, Corning, Wuxi App Tec & Sartorious
Business Wire - Fri Oct 03, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6zhblj/cell_line) has announced the addition of the "Cell Line Development Market by Product, Source, Type & by Application - Analysis & Global Forecast to 2019" report to their offering.
Cell Line Development Market Outlook 2019: Key Players in the $3.9 Billion Industry are ATCC, Lonza Group, Thermo Fisher Scientific, GE, Sigma Aldrich, Selexis, ECACC, Corning, Wuxi App Tec & Sartorious
M2 - Fri Oct 03, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rlcrnv/cell_line) has announced the addition of the "Cell Line Development Market by Product, Source, Type & by Application - Analysis & Global Forecast to 2019" report to their offering. The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019 The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years. The cell line development market, by type is divided into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines accounted for the largest share of the market, by type. However, the primary cell lines segment is expected to grow at the fastest rate in the market, by type. Based on the source of cell lines, the market is segmented into mammalians, insects, and amphibians. The mammalian segment is the largest and the fastest growing segment of the market, by source. On the basis of applications, the market is segmented into bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. In 2014, the bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and manufacturing of recombinant protein therapeutics. The key factors that are expected to spur this market are increased demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies. However, developing stable and authentic cell lines poses a major challenge for this market. Some of the opportunities for cell line development market are low income countries and increasing risk of pandemics and communicable diseases. Report Scope Product - Equipment - Media - Reagents Application - Bioproduction - Tissue Engineering & Regenerative Medicine - Toxicity Testing - Research - Drug Discovery Source Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Cell Line Development Market, By Product 8 Cell Line Development Market, By Source 9 Cell Line Development Market, By Type 10 Global Cell Line Development Market, By Application 11 Cell Line Development Market, By Geography 12 Competitive Landscape 13 Company Profiles For more information visit http://www.researchandmarkets.com/research/rlcrnv/cell_line
Global Cell Culture Market Forecasts and Opportunities, 2018
M2 - Tue Sep 16, 7:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zttdhr/cell_culture) has announced the addition of the "Global Cell Culture Market Forecasts and Opportunities, 2018" report to their offering. The global cell culture market was valued at $ 14,772 million in 2013 and is poised to grow at a CAGR of 10.71% between 2013 and 2018, to reach $24,574 million in 2018. Rapid increase in biopharmaceutical production and increasing healthcare expenditure will be the two most important growth drivers for this market in the forecast period from 2013 to 2018. Biopharmaceutical production had the largest share of the cell culture market in 2013. According to IMS Health, biopharmaceutical is expected to one of the fastest growing pharmaceutical segment between 2012 and 2017. The increasing demand for biopharmaceutical products like vaccines and antibodies coupled with strong pipelines for biopharmaceuticals and increasing healthcare expenditure will drive the demand for cell culture products. The global cell culture market comprises of cell culture equipment and cell culture media, sera, and reagent markets. The cell culture equipment market consists of five equipment segments, namely, lab equipment, bio-safety cabinets, consumables, storage equipment, and sterilization equipment. The cell culture media, sera, and reagents market consists of six segments, namely, serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents. Scope of the Report Cell Culture Equipment Market - Cell Culture Lab Equipment - Cell Culture Bio-safety Cabinets - Cell Culture Consumables - Cell Culture Storage Equipment - Cell Culture Sterilization Equipment Cell Culture Media, Sera, & Reagents Market - Serum - Media - Lab Reagents for Cell Culture - Contamination Detection Kits - Cryoprotective Agents - Other Reagents Cell Culture Market, By Application - Biopharmaceutical Production - Tissue Culture & Engineering - Vaccine Production - Drug Screening & Development - Gene Therapy - Toxicity Testing - Cancer Research - Other Applications Companies Mentioned - Becton, Dickinson And Company - Corning, Inc. - Eppendorf Ag - General Electric - Lonza Group Ltd. - Merck Kgaa - Promocell Gmbh - Sartorius Ag - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/zt...ll_culture
SIAL: 138.20 (+0.07)
Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014
M2 - Mon Sep 01, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bmprtw/analyzing_the) has announced the addition of the "Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014" report to their offering. This research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expires of blockbuster drugs and the impact of the economic recession on the market. The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the end of 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market. The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market. Key Topics Covered: 1. Executive Summary 2. Introduction to Active Pharmaceutical Ingredients 3. Global Market for Active Pharmaceutical Ingredients (APIs) 4. Impacts on the Global API Market 5. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific 6. Market for Active Pharmaceutical Ingredients (APIs) in Europe 7. Market for Active Pharmaceutical Ingredients (APIs) in North America 8. Major Industry Players - Actavis Plc - Albemarle Corporation - Ampac Fine Chemicals LLC - Aptuit, Inc - Aurobindo Pharma - BASF SE - Biocon Ltd - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Cambrex Corporation - Cipla Ltd - Covidien Plc - Daiichi Fine Chemical Co., Ltd. - Dishman Pharmaceuticals & Chemicals Ltd. - Dr. Reddy's Laboratories Limited - Fabbrica Italiana Sintetici - Hospira Inc - Koninklijke DSM N.V. - Lonza Group AG - Lupin Limited - Matrix Laboratories Limited/Mylan Inc - Novartis AG - Novasep Holding - Pfizer Inc - Ranbaxy Laboratories - Sandoz International GmbH - Sigma-Aldrich Corporation - Sun Pharmaceutical Industries Limited - Teva Pharmaceutical Industries Limited - WuXi AppTec, Inc For more information visit http://www.researchandmarkets.com/research/bm...lyzing_the
CBM: 32.96 (+0.09), PFE: 34.64 (-0.23), BMY: 60.04 (+0.56), ALB: 54.59 (+0.63), SIAL: 138.20 (+0.07), TEVA: 56.77 (-0.58), NVS: 102.20 (-0.17)
Active Pharmaceutical Ingredients Global Market - Forecast to 2020
M2 - Tue Aug 26, 10:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n53c3t/active) has announced the addition of the "Active Pharmaceutical Ingredients Global Market - Forecast to 2020" report to their offering. Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source. Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives Overall API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019. The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation. Globally North America accounts the largest share in the API market. Asia-Pacific is second largest followed by Europe. Asia is growing at a highest CAGR compared to North America followed by Europe. The key players of Active Pharmaceutical Ingredient market are Sandoz-Lek-Biochemie (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (India), AstraZeneca plc (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.) and F. Hoffmann-La Roche Ltd. (Switzerland). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Active Pharmaceuticals Ingredients by Synthesis 5. Active Pharmaceuticals Ingredients by Therapeutic Applications 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Albemarle Corporation - Aurobindo - Boehringer Ingelheim GmbH - Cambrex Corporatio - Dr. Reddy's Lab - Lonza Group - Lupin - Novartis - Ranbaxy Laboratories - Teva Active Pharmaceutical Industries Limited For more information visit http://www.researchandmarkets.com/research/n53c3t/active
CBM: 32.96 (+0.09), ALB: 54.59 (+0.63), PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), NVS: 102.20 (-0.17)
Growth Factors (Blood and Tissue) Market 2014 - Global Strategic Business Report
M2 - Thu Aug 14, 2:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bqzzts/growth_factors) has announced the addition of the "Growth Factors (Blood and Tissue) - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) - Tissue Growth Factors. The report profiles 90 companies including many key and niche players such as: - Alseres Pharmaceuticals, Inc. - Amgen, Inc. - Bayer HealthCare Pharmaceuticals, Inc. - Biogen Idec Inc - BioMimetic Therapeutics, Inc. - Biopharm GmbH - Bolder Biotechnology, Inc. - F. Hoffmann-La Roche Ltd - Chugai Pharmaceutical Co. Ltd. - Genentech, Inc. - FibroGen, Inc. - Johnson & Johnson - Janssen Biotech, Inc. - Lonza Group - Merck Serono International S.A. - NsGene A/S - PeproTech, Inc. - Reliance GeneMedix Plc - Sangamo BioSciences, Inc. - Sanofi - Shantha Biotechnics - Scil Proteins GmbH - Wockhardt Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Growth Factors An Overview 3. Research Studies & Clinical Trials 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 90 (including Divisions/Subsidiaries 95) - The United States (42) - Japan ( - Europe (19) - France (1) - Germany ( - The United Kingdom (1) - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (24) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/bq...th_factors
JNJ: 99.62 (+1.18), BIIB: 391.66 (-0.45), MRK: 58.81 (-0.07), SGMO: 15.40 (+0.14), AMGN: 153.48 (+0.30)
U.S. Antimicrobial Plastics Market - Industry Analysis 2014 - 2020 (Appliances, Personal Care, Packaging, Automotive, Building & Construction, Healthcare)
M2 - Mon Aug 11, 6:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j6gfj6/u_s) has announced the addition of the "U.S. Antimicrobial Plastics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. Antimicrobial plastics are molded polymers infused with antimicrobials to inhibit the growth of various harmful microorganisms such as fungi and bacteria. Antimicrobial plastics are used in various industries such as healthcare, automotives, building & construction, electronics, packaging and consumer goods. Additionally, they are used in niche applications such as pipes, plastic water storage containers, waste bins and lids. Rising awareness among consumers regarding good health and cleanliness is expected to be one of the primary factors driving the growth of the antimicrobial plastics market. The report on U.S.antimicrobial plastics market report forecasts and analyzes the antimicrobial plastics market on a regional level. The forecast demand on the global level is based on volume (tons) and revenue (USD million) for the period ranging from 2014 to 2020. The study on U.S. antimicrobial plastics market outlines drivers and restraints of the polyester market and their impact on market growth during the mentioned time period. Additionally, the study includes opportunities available for the market on the regional and level and their effect during the said forecast period. All plastics infused with antimicrobials have been classified as antimicrobial plastics under the scope of this study. Personal care includes packaging of personal care products. Packaging of healthcare products has been classified under the packaging segment. Packaging typically includes foods, beverages and pharmaceuticals. In other words, the segment includes all types of packaging, except for personal care products. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Antimicrobial Plastics - Industry Analysis Chapter 4 Antimicrobial Plastics Market - Application Analysis Chapter 5 Company Profiles Companies Mentioned - AkzoNobel N.V. - BASF SE - Bayer AG - Diamond Vogel - E. I. du Pont de Nemours and Company - Ishizuka Glass Co. Ltd. - Lonza Group AG - Momentive Performance Materials Inc. - Sciessent LLC - Sherwin-Williams - Sinanen Zeomic Co Ltd - Teknor Apex - The Dow Chemical Company For more information visit http://www.researchandmarkets.com/research/j6gfj6/u_s
SHW: 285.00 (+1.98)
Global Cell Culture Market 2014-2018: Equipment, Reagent, & Application Breakdown
M2 - Thu Jul 17, 9:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c3qkn9/cell_culture) has announced the addition of the "Cell Culture Market by Equipment, by Reagent, by Application - Global Forecast to 2018" report to their offering. The global cell culture market was valued at an estimated $14,772 million in 2013. This market is expected to grow at a CAGR of 10.71% between 2013 and 2018. Cell culture is the most widely used technique for biopharmaceutical production. A large quantity of cell culture media, sera, and reagents is required for biopharmaceutical production. Biopharmaceutical production is the largest application segment for the cell culture market in 2013. Furthermore, according to IMS Health, biopharmaceutical is expected to be one of the fastest growing pharmaceutical segments by 2017. Growth in the biopharmaceutical industry, aided by strong pipelines for antibiotics and vaccine products will drive the growth of the cell culture market. This report segments the global cell culture market into two market segments, namely, the cell culture equipment and cell culture media, sera, and reagents. The cell culture equipment market is further subsegmented into lab equipment, bio-safety cabinets, consumables, storage equipment, and sterilization equipment. The lab equipment segment is further segmented into cell counters, centrifuges, fermentors and bioreactors, and incubators. The storage equipment segment is further segmented into cryogenic storage and refrigerators and freezers. The cell culture media, sera, and reagents market is subsegmented into serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents. The lab reagents segment is further subsegmented into balanced salt solutions, buffers and chemicals, cell dissociation reagents, and supplements and growth factors. The media segment is further subsegmented into basal media, reduced serum media, and serum-free media. Scope of the Report Cell Culture Equipment Market - Cell Culture Lab Equipment - - Cell Counters - - Fermentors & Bioreactors - - Incubators - - Centrifuge - Cell Culture Bio-safety Cabinets - Cell Culture Consumables - Cell Culture Storage Equipment - - Cell Culture Refrigerators & Freezers - - Cell Culture Cryogenic Storage - Cell Culture Sterilization Equipment Cell Culture Media, Sera, & Reagents Market - Serum - - Fetal Bovine Serum & Other Animal Sera - Media - - Basal Media - - Reduced Serum Media - - Serum-free Media - Lab Reagents for Cell Culture - - Cell Culture Supplements & Growth Factors - - Buffers & Chemicals - - Cell Dissociation Reagents - - Balanced Salt Solutions - Contamination Detection Kits - Cryoprotective Agents - Other Reagents Cell Culture Market, By Application - Biopharmaceutical Production - Tissue Culture & Engineering - Vaccine Production - Drug Screening & Development - Gene Therapy - Toxicity Testing - Cancer Research - Other Applications Companies Mentioned - Becton, Dickinson and Company - Corning, Inc. - Eppendorf AG - Lonza Group Ltd. - Merck Kgaa - Promocell GMBH - Sartorius AG - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/c3...ll_culture
SIAL: 138.20 (+0.07)
Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 with Abbott Laboratories, Aurobindo Pharma, Mylan & Teva Pharmaceutical Industries Dominating
M2 - Mon Feb 09, 10:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/jgfvvc/active) has announced the addition of the "Active Pharmaceutical Ingredients (API) Market in the US 2015-2019" report to their offering. The API market in the US to grow at a CAGR of 7% over the period 2014-2019 Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis. One major trend upcoming in the market is the strong focus on the development and introduction of high-potency API. Such products are increasingly used in oncology and for the provision of targeted therapy. According to the report, one of the key drivers contributing to the growth of the API market in the US is the strong preference for generic drugs compared with innovative or branded drugs. The use of generic equivalents is preferred to innovative drugs, with countries encouraging doctors and pharmacists to prescribe such equivalents. Further, the report states that stringent regulationse one of the major challenges that the market faces. Vendors are required to comply with elaborate procedures prior to product commercialization. For instance, compliance with GMP requirements increases costs for vendors. Key Vendors - Abbott Laboratories - Aurobindo Pharma - Mylan - Teva Pharmaceutical Industries Other Prominent Vendors - Albemarle - Aptuit - BASF - Biocon - Boehringer Ingelheim - Cambrex - Cipla - Dr. Reddy's Laboratories - Hospira - Lonza Group - Novartis - Pfizer - Sigma-Aldrich - Sun Pharmaceutical Industries Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - API Market in the US - Market Segmentation by Type of Production Process - Market Segmentation by Type of Product - Market Segmentation by Type of Players - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/jgfvvc/active
ABT: 46.09 (+0.87), CBM: 32.96 (+0.09), TEVA: 56.77 (-0.58), NVS: 102.20 (-0.17)
Global L-carnitine Industry Market Report 2015
M2 - Wed Jan 28, 9:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/7bv6nf/global) has announced the addition of the "Global L-carnitine Industry Report 2015" report to their offering. The Global L-carnitine Industry Report 2015 is a professional and in-depth study on the current state of the L-carnitine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The L-carnitine market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. L-carnitine industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on thirteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The L-carnitine industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 168 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Key Topics Covered: - L-carnitine Industry Overview - L-carnitine International and China Market Analysis - L-carnitine Technical Data and Manufacturing Plants Analysis 2014 - L-carnitine Production by Regions By Technology By Applications 2009-2015 - L-carnitine Manufacturing Process and Cost Structure - L-carnitine Productions Supply Sales Demand Market Status and Forecast 2009-2015 - L-carnitine Key Manufacturers Analysis - Up and Down Stream Industry Analysis - L-carnitine Marketing Channels Analysis - L-carnitine Productions Supply Sales Demand Market Status and Forecast 2015-2020 - L-carnitine Supply Chain Relationship Analysis - L-carnitine New Project Investment Feasibility Analysis - Global and China L-carnitine Industry Research Conclusion Companies Mentioned - AIDP (USA) - HuangGang HuaYang (China) - Hubei Hongjing (China) - Kaiyuan Hengtai (China) - Lonza Group (Switzerland) - NINGBO HONOR CHEMTECH (CHINA) - Northeast Pharmaceutical (China) - ShangHai KangXin (China) - Shenyang Koncepnutra (China) - Wuhan Saiguang (China) - Xinxiang Kangjian (China) - Yichang Yongnuo (China) - ZHEJIANG JIASHAN CHENGDA (CHINA) For more information visit http://www.researchandmarkets.com/research/7bv6nf/global
Water Treatment Chemicals Trends & Forecasts to 2019: Corrosion Inhibitor, Scale Inhibitor, Coagulants & Flocculants, Biocides & Disinfectants, Chelating Agents, Anti-foaming Agents, pH Adjusters & Stabilizers
M2 - Tue Jan 13, 10:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/c96mvk/water_treatment) has announced the addition of the "Water Treatment Chemicals Market By Type, By Application - Global Trends & Forecasts to 2019" report to their offering. The water treatment chemicals market is projected to grow at a CAGR of 5.8% between 2014 and 2019 to reach $33,289 million by 2019 in terms of value. Water treatment chemicals are chemical compounds used to remove the impurities from water. Use of water is ever increasing with the economic development and rapid urbanization in emerging countries. The industrial sector requires water for cooling, washing, and processing in different applications including power generation, steel, chemicals, pulp & paper, and petroleum refining. Water treatment chemicals are also used to treat municipal water.. In the recent years, water treatment chemicals have been used in the treatment of agricultural wastewater. The increasing population and industrial activities are driving the demand for clean and fresh water. The consumption of water treatment chemicals depends on the source of water; which can be sea, ground, or municipal drinking water. The quality of water depends on various defined parameters such as TDS (Total Dissolved Solids), hardness, pH, and alkalinity. The demand is also influenced by different such as water availability, its usage pattern, presence of pollutants, government policies, and trade-offs among various chemical compounds. Globally, the Asia-Pacific region dominated the water treatment chemicals market size in terms of both value and volume in 2013. China and India are the major countries with a huge demand for water treatment chemicals. Market players concentrate on expanding their market reach. Other development strategies adopted by market players are new product launches, agreements & collaborations, and mergers & acquisitions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Water Treatment Chemicals Market, By Product Type 8 Global Water Treatment Chemicals Market, By Application 9 Global Water Treatment Chemicals Market - By Region 10 Competitive Landscape 11 Company Profiles - Air Products And Chemicals, Inc. - Akzonobel Nv - Ashland Corporation - Basf Se - Buckman Laboratories International Inc. - Bwa Water Additives UK Limited - Cortec Corporation - Ecolab (Nalco Company) - Ge Water & Process Technologies - Kemira Oyj - Lonza Group LTD. - The Dow Chemical Ompany For more information visit http://www.researchandmarkets.com/research/c9..._treatment
APD: 152.81 (+0.59), ECL: 111.62 (+0.85)
Global Active Pharmaceutical Ingredients (API) Market Forecasts 2014-2020: Market Expected to Grow by 8% (Updated Edition)
M2 - Wed Jan 07, 2:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/55tnr3/active) has announced the addition of the "Active Pharmaceutical Ingredients (API) Global Market - Forecast to 2020" report to their offering. The global API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019 The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation. Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source. Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Global API Market Overview 5 Global API Market, By Therapeutic Application 6 Regional Market Analysis 7 Company Developments 8 Major Player Profiles - Albemarle Corporation - Aurobindo Pharma Limited - Boehringer Ingelheim Gmbh - Dr. Reddy'S Laboratories Limited - Fresenius Kabi - Lonza Group Ltd - Lupin Limited - Novartis International Ag - Ranbaxy Laboratories Limited - Sun Pharmaceuticals Industries Ltd - Teva Active Pharmaceutical Ingredients For more information visit http://www.researchandmarkets.com/research/55tnr3/active
ALB: 54.59 (+0.63), NVS: 102.20 (-0.17)
Animal Feed Additives - Global Strategic Business Report
M2 - Tue Dec 16, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/24vhpg/animal_feed) has announced the addition of the "Animal Feed Additives - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Animal Feed Additives in US$ Million by the following Product Segments: Antibiotics/Antibacterials, Vitamins, Antioxidants, Amino Acids, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 272 companies including many key and niche players such as: - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc. - Alltech Inc. - Archer Daniels Midland Company Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study - Product Definitions - Antibiotics/Antibacterials - Vitamins - Antioxidants - Amino Acids - Others II. EXECUTIVE SUMMARY 1. OUTLOOK 2. COMPETITIVE LANDSCAPE 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. REGULATORY & ENVIRONMENTAL ANALYSIS 6. PRODUCT INTRODUCTIONS/APPROVALS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT GLOBAL PLAYERS - ADDCON Group - Adisseo France SAS - Ajinomoto Co., Inc - Ajinomoto Eurolysine S.A.S - Alltech Inc - Archer Daniels Midland Company - BASF SE - Biovet JSC - Cargill, Inc - Provimi Holding - Chr. Hansen - DSM Nutritional - DuPont - Elanco Animal Health - Evonik Industries AG (Germany) - InVivo NSA S.A. (France) - Kemin Industries, Inc. (US) - Lonza Group Ltd (Switzerland) - Novozymes A/S (Denmark) - Novus International, Inc. (US) - Nutreco N.V (the Netherlands) - Phibro Animal Health Corporation (US) - Tessenderlo Group (Belgium) - The Mosaic Company (US) - Zoetis, Inc. (US) 9. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. MIDDLE EAST/AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE For more information visit http://www.researchandmarkets.com/research/24...nimal_feed
ZTS: 45.46 (-0.33), ADM: 48.10 (+0.66), PAHC: 30.85 (+0.36)
Global Cell Line Development (Equipment, Media and Reagents) Market Research Report 2014-2019
M2 - Mon Dec 01, 7:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/969944/cell_line) has announced the addition of the "Cell Line Development Market by Product, Source, Type & by Application - Analysis & Global Forecast to 2019" report to their offering. The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019 The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years. Over the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have led to growth in a number of applications of cell lines such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. Cell line development media and reagents account for the largest share in the global cell line development market, as they have numerous applications in areas such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. The reagents segment accounted for the maximum share of the cell line development media and reagents market. The bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and in manufacturing of recombinant protein therapeutics. North America accounted for the largest share of the global cell line development market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cell line development market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to serve as revenue pockets for cell line manufacturers. Scope of the Report - Product (Equipment, Media and Reagents) - Source - Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Cell Line Development Market, By Product 8 Cell Line Development Market, By Source 9 Cell Line Development Market, By Type 10 Global Cell Line Development Market, By Application 11 Cell Line Development Market, By Geography 12 Competitive Landscape 13 Company Profiles - American Type Culture Collection (ATCC) - Corning, Inc. - European Collection of Cell Cultures (ECACC) - GE Healthcare - Lonza Group AG - Sartorius AG - Selexis SA - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. - Wuxi Apptec For more information visit http://www.researchandmarkets.com/research/969944/cell_line
SIAL: 138.20 (+0.07)
Global Active Pharmaceutical Ingredients Market - Trends & Forecast to 2020 for the $190 Billion Industry
M2 - Thu Nov 20, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/sm7qx5/global_active) has announced the addition of the "Global Active Pharmaceutical Ingredients Market - Trends & Forecast to 2020" report to their offering. The global Active Pharmaceutical Ingredient market is expected to reach a market size approximately $190 billion by 2020, growing at a CAGR of more than 6.5% from 2014 to 2020 API market is mainly driven by the factors such as patent expiration of major drugs, increased generic medicine sales and high uptake of biologics. High Potential Active Pharmaceutical Ingredients (HPAPI) are also driving the API market growth globally as these compounds are very effective in treatment of diseases such as cancer, respiratory disorders and hormonal imbalances and HPAPI growth is mainly driven by its therapeutic applications in Oncology. Depending on the product type the API market is segmented into synthetic API, Biotech API, and HPAPI. Synthetic API commanded the largest share in 2013 and is growing at a steady pace, whereas the biotech API is expected to register the highest CAGR during the forecast period, strongly driven by the monoclonal antibodies and recombinant proteins. Depending on the applications the API market is categorized into oncology, cardiovascular and hematopoietic system, central nervous system, anti-infective, gastrointestinal, respiratory system, metabolic disorders, genito-urinary disorders, and others. Cardiovascular commanded the largest share of more than 40% in 2013 and is growing at a steady pace, whereas oncology is expected to register the highest CAGR during the forecast period. HPAPI commanded the largest share in the oncology application segment in 2013 and is growing at a highest CAGR in the anti-infectives segment. Scope of the Report Global API Market, by Synthesis: - Synthetic Chemical API - Branded/Innovative - Generic/Non-branded - Biotech API - Biologics - Biosimilars - Mammalian cell culture - Monoclonal antibodies - Recombinant proteins - Vaccines - Insulin analog - Growth hormone manufacturing - Interferon manufacturing - HPAPI Global API Market, by Business type: - Captive - Merchant Global API Market, by Therapeutic Applications: - Anti-infectives - Oncology - Cardiovascular and hematopoietic system - Central nervous system - Respiratory system - Gastrointestinal disorders - Hormone-related disorders - Metabolic disorders - Genitourinary disorders - Musculo-skeletal disorders - Others Companies Mentioned - Albemarle Corporation - Aurobindo - Boehringer Ingelheim GmbH - Cambrex Corporatio - Dr. Reddy's Lab - Lonza Group - Lupin - Novartis - Ranbaxy Laboratories - Teva Active Pharmaceutical Industries Limited For more information visit http://www.researchandmarkets.com/research/sm...bal_active
CBM: 32.96 (+0.09), ALB: 54.59 (+0.63), NVS: 102.20 (-0.17)
Global Gut and Digestive Health Ingredients and Consumer Products Market Trends and Insights 2013-2018
M2 - Fri Nov 07, 6:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/n2d9z7/gut_and_digestive) has announced the addition of Canadean Ltd's new report "Gut and Digestive Health Ingredients and Consumer Products - Market Trends and Insights" to their offering. Millions of consumers are facing gut and digestive health disorders which provides business opportunities for dietary supplement producers looking to provide effective products that can help manage illness and intolerances, as well as promote overall health. Global demand for probiotics is predicted to grow at a CAGR of 6.8% from 2013 to 2018. The gastrointestinal health supplement category saw $1.4 billion in consumer sales in 2011, a 14% percent increase over the previous year. The regulatory environment is difficult and the industry is daring flexible interpretations of the regulations in certain regions. Manufacturers will need to consult with local authorities before making a decision on how to represent probiotics or prebiotics on labels. However, a lack of understanding amongst the public regarding fiber importance in the diet, and how much fiber should be consumed on a daily basis, remains a communication hurdle for product manufacturers. Certain polyphenols seem to act as prebiotic-type substances and offers innovation opportunities for the industry. Additionally, some phenolic acids affect the expression and activity of enzymes involved in the production of inflammatory mediators thought to be important in the development of gut disorders, including colon cancer. Another prospect group of ingredients are dietary enzymes targeting a wide range of digestive health issues. As consumer awareness for this unique category of dietary supplements grows, companies could begin to combine enzymes with other nutrients that can enhance beneficial effects in the gut. It is expected that major industry participants such as Nestec SA (Switzerland), Alimentary Health Limited, and Nutrica NV will increase their R&D efforts to develop new products and new product applications, along with their approval in various geographic regions to gain a competitive edge. Universities and other small organizations and companies around the world also play a dynamic role in the development of the industry. Key Topics Covered: 1.Introduction 2. Executive Summary 3. Introduction to Gut and Digestive Health 4. Gut and Digestive Health Ingredients 5. Consumer Product Manufacturers 6. General Sources 7. Appendix Companies Mentioned - Beneo BV - Cargill Inc. - Chr Hansen Holdings A/S - Cosucra Group - Danone - Dupont Danisco A/S - Ganeden Biotech Inc. - General Mills - Gnosis SpA - Hipp Uk Limited - Kellogg's - Lesaffre Group - Liberte - Lonza Group Ltd - NZ Extracts Ltd - Natural Remedies Pvt Ltd - Nestle - Next Food - Parmalat - Planters - Roxlor LLC - Swanson etc. - Tate and Lyle - Vital solutions For more information visit http://www.researchandmarkets.com/research/n2..._digestive
GIS: 52.48 (-0.45)
Lonza Group Ltd. and CAMO Software AS have entered into agreement to deliver software solution.
M2 - Fri Nov 07, 6:28AM CST
Lonza Group Ltd. and CAMO Software AS have entered into an agreement to deliver a PAT software solution to the Lonza Visp site. The solution will be integrated with existing production systems at Lonza offering greater flexibility with minimal system duplication.
Global Polyether Polyols Market Research Report 2014-2019
M2 - Tue Nov 04, 10:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/pdtxkh/micro_market) has announced the addition of the "Micro Market Monitor : Global Polyether Polyols Market Research Report" report to their offering. Polyether Polyols and Polyester Polyols adds up to total Polymeric Polyols market. Polyether Polyols can be segmented by Geographies, Companies, Ingredients, Applications and Submarkets. Companies of this market are Dow Chemical, Bayer MaterialScience, BASF SE (Parent), Shell Chemicals Ltd, Huntsman Corporation, Carpenter Chemical, PERSTORP AB, Repsol, Rabigh, Dong Da Chemical Co, CPSC, Korea Polyol and Other Companies. Ingredients of this market are Propylene Oxide and Ethylene Oxide. Applications of this market are Electroactive Polymers, Polyurethane CASE, Polyurethane Flexible Foam and Polyurethane Rigid Foam. Submarkets of this market are Bio-Based Polyether Polyols and Petro-Based Polyether Polyols. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Global Polyether Polyols Market, By Application, 2014-2019 6 Global Polyether Polyols Market, By Geography 7 Company Profiles - Baalbaki Group S.A. - Basf Se - Bayer Ag - Biotor Industries Limited - Cargill Incorporated - Chemtura Corporation - Coim S.P.A - Expanded Polymer Systems Pvt. Ltd - Huntsman Corporation - Invista - Lonza Group Ltd - Manali Petrochemicals Ltd - Nanjing Hongbaoli Co. Ltd - Pcc Rokita Sa - Perstorp Ab - Royal Dutch Shell Plc - Royal Industries - Shandong Dongda Chemical Industry Co. Ltd - Shraddha Associates (Gujarat) Pvt. Ltd - Stepan Company - The Dow Chemical Company - Vertellus Specialties Inc. For more information visit http://www.researchandmarkets.com/research/pd...cro_market
CHMT: 24.77 (+0.81), DOW: 49.44 (+0.29), SCL: 41.23 (+0.34)
Fermentation Chemicals - 2014 Global Strategic Business Report
M2 - Thu Oct 23, 5:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7b995t/fermentation) has announced the addition of the "Fermentation Chemicals - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Fermentation Chemicals in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 86 companies including many key and niche players. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Analysis 2. Competition 3. Market Trends 4. Product Overview 5. End-Use Market Analysis 6. Product Innovations/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 86 (including Divisions/Subsidiaries - 100) - The United States (40) - Canada (1) - Japan (10) - Europe (34) - - France (9) - - Germany (
- - The United Kingdom (3) - - Italy (2) - - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (11) - Latin America (1) - Africa (1) - Middle East (2) Companies Featured: - AB Enzymes GmbH - Adisseo France S.A.S - Ajinomoto Company, Inc. - Amano Enzyme Inc. - Amino GmbH - Asahi Kasei Corporation - Archer Daniels Midland Company - Ashland, Inc. - BASF SE - Cargill, Inc. - Chr. Hansen A/S - Corbion NV - Dow Chemical Company - DuPont Nutrition and Health - Evonik Industries AG - Gadot Biochemical Industries Ltd. - Jungbunzlauer AG - Kyowa Hakko Bio Co. Ltd. - Lonza Group AG - MGP Ingredients, Inc. - Novozymes A/S - Novus Biologicals, LLC - Roquette Freres SA - Royal DSM - Tate & Lyle PLC - Wacker Chemie AG For more information visit http://www.researchandmarkets.com/research/7b...rmentation ASH: 127.58 (+1.21), ADM: 48.10 (+0.66), MGPI: 14.00 (-0.39), DOW: 49.44 (+0.29)
U.S. Antimicrobial Plastics Market Outlook 2020
M2 - Tue Oct 14, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/23pc35/u_s) has announced the addition of the "U.S. Antimicrobial Plastics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The market for antimicrobial plastics has grown rapidly over the past few years. This trend is likely to continue in the near future. Research is being conducted to discover a new variety of plastic compounds in order to develop implants and biomedical devices with higher resistance to microbial adhesion and biofilm formation. A number of polymers have been developed that can be incorporated into cellulose and other materials. This would result in significant advances in various industries such as textiles, catheter tubes, food packaging, wound dressing and sterile surfaces. A greater need for materials that fight infection would act as an incentive for the discovery and usage of antimicrobial polymers. Healthcare was the largest segment, accounting for about 44% of the total U.S. antimicrobial plastics industry in 2013. This was followed by packaging and electronic & consumer appliances segments. This trend is anticipated to continue during the forecast period. The usage of antimicrobial plastics in healthcare applications helps prevent and control infection. Demand for antimicrobial plastics in the U.S. is estimated to increase significantly due to the implementation of stringent regulations regarding healthcare and hygiene. Furthermore, personal care packaging, including skin care and hair care products and cosmetics, coupled with packaging of pharmaceuticals and food & beverages is projected to boost demand for antimicrobial plastics during the forecast period. Antimicrobial plastics are governed by the Environmental Protection Agency (EPA) of the U.S. According to the EPA, plastics containing antimicrobials qualify as treated articles. Furthermore, antimicrobials are considered pesticides under the EPA. Due to this, antimicrobial plastics need to be registered with the EPA. There are several legislations in relation to antimicrobial plastics in medical devices. Most medical devices are governed by the EPA. However, antimicrobials that are intended to be released by the medical device are regulated by the FDA and classified as drugs. Application Segment Analysis - Electronics & consumer appliances - Personal care - Packaging - Automotive - Building & construction - Healthcare - Others (Includes sportswear, waste bins, etc.) Key players in the U.S. antimicrobial plastics market include - AkzoNobel - BASF - Bayer - The Dow Chemical Company - Lonza Group - Sherwin-Williams For more information visit http://www.researchandmarkets.com/research/23pc35/u_s
SHW: 285.00 (+1.98)
Research and Markets: Cell Line Development Market Outlook 2019: Key Players in the $3.9 Billion Industry are ATCC, Lonza Group, Thermo Fisher Scientific, GE, Sigma Aldrich, Selexis, ECACC, Corning, Wuxi App Tec & Sartorious
Business Wire - Fri Oct 03, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6zhblj/cell_line) has announced the addition of the "Cell Line Development Market by Product, Source, Type & by Application - Analysis & Global Forecast to 2019" report to their offering.
Cell Line Development Market Outlook 2019: Key Players in the $3.9 Billion Industry are ATCC, Lonza Group, Thermo Fisher Scientific, GE, Sigma Aldrich, Selexis, ECACC, Corning, Wuxi App Tec & Sartorious
M2 - Fri Oct 03, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rlcrnv/cell_line) has announced the addition of the "Cell Line Development Market by Product, Source, Type & by Application - Analysis & Global Forecast to 2019" report to their offering. The global cell line development market is expected to reach $3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019 The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years. The cell line development market, by type is divided into primary cell lines, continuous cell lines, hybridomas, and recombinant cell lines. Recombinant cell lines accounted for the largest share of the market, by type. However, the primary cell lines segment is expected to grow at the fastest rate in the market, by type. Based on the source of cell lines, the market is segmented into mammalians, insects, and amphibians. The mammalian segment is the largest and the fastest growing segment of the market, by source. On the basis of applications, the market is segmented into bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. In 2014, the bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and manufacturing of recombinant protein therapeutics. The key factors that are expected to spur this market are increased demand for monoclonal antibodies, rising vaccine production, and use of innovative technologies. However, developing stable and authentic cell lines poses a major challenge for this market. Some of the opportunities for cell line development market are low income countries and increasing risk of pandemics and communicable diseases. Report Scope Product - Equipment - Media - Reagents Application - Bioproduction - Tissue Engineering & Regenerative Medicine - Toxicity Testing - Research - Drug Discovery Source Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Cell Line Development Market, By Product 8 Cell Line Development Market, By Source 9 Cell Line Development Market, By Type 10 Global Cell Line Development Market, By Application 11 Cell Line Development Market, By Geography 12 Competitive Landscape 13 Company Profiles For more information visit http://www.researchandmarkets.com/research/rlcrnv/cell_line
Global Cell Culture Market Forecasts and Opportunities, 2018
M2 - Tue Sep 16, 7:58AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zttdhr/cell_culture) has announced the addition of the "Global Cell Culture Market Forecasts and Opportunities, 2018" report to their offering. The global cell culture market was valued at $ 14,772 million in 2013 and is poised to grow at a CAGR of 10.71% between 2013 and 2018, to reach $24,574 million in 2018. Rapid increase in biopharmaceutical production and increasing healthcare expenditure will be the two most important growth drivers for this market in the forecast period from 2013 to 2018. Biopharmaceutical production had the largest share of the cell culture market in 2013. According to IMS Health, biopharmaceutical is expected to one of the fastest growing pharmaceutical segment between 2012 and 2017. The increasing demand for biopharmaceutical products like vaccines and antibodies coupled with strong pipelines for biopharmaceuticals and increasing healthcare expenditure will drive the demand for cell culture products. The global cell culture market comprises of cell culture equipment and cell culture media, sera, and reagent markets. The cell culture equipment market consists of five equipment segments, namely, lab equipment, bio-safety cabinets, consumables, storage equipment, and sterilization equipment. The cell culture media, sera, and reagents market consists of six segments, namely, serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents. Scope of the Report Cell Culture Equipment Market - Cell Culture Lab Equipment - Cell Culture Bio-safety Cabinets - Cell Culture Consumables - Cell Culture Storage Equipment - Cell Culture Sterilization Equipment Cell Culture Media, Sera, & Reagents Market - Serum - Media - Lab Reagents for Cell Culture - Contamination Detection Kits - Cryoprotective Agents - Other Reagents Cell Culture Market, By Application - Biopharmaceutical Production - Tissue Culture & Engineering - Vaccine Production - Drug Screening & Development - Gene Therapy - Toxicity Testing - Cancer Research - Other Applications Companies Mentioned - Becton, Dickinson And Company - Corning, Inc. - Eppendorf Ag - General Electric - Lonza Group Ltd. - Merck Kgaa - Promocell Gmbh - Sartorius Ag - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/zt...ll_culture
SIAL: 138.20 (+0.07)
Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014
M2 - Mon Sep 01, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bmprtw/analyzing_the) has announced the addition of the "Analyzing the Global Market for Active Pharmaceutical Ingredients - 2014" report to their offering. This research analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and upcoming patent expires of blockbuster drugs and the impact of the economic recession on the market. The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the end of 2014, there is expected to be a major impact on the global API industry. Revenues of the API markets are likely to be affected as generic drugs take up the market. The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market. Key Topics Covered: 1. Executive Summary 2. Introduction to Active Pharmaceutical Ingredients 3. Global Market for Active Pharmaceutical Ingredients (APIs) 4. Impacts on the Global API Market 5. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific 6. Market for Active Pharmaceutical Ingredients (APIs) in Europe 7. Market for Active Pharmaceutical Ingredients (APIs) in North America 8. Major Industry Players - Actavis Plc - Albemarle Corporation - Ampac Fine Chemicals LLC - Aptuit, Inc - Aurobindo Pharma - BASF SE - Biocon Ltd - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Cambrex Corporation - Cipla Ltd - Covidien Plc - Daiichi Fine Chemical Co., Ltd. - Dishman Pharmaceuticals & Chemicals Ltd. - Dr. Reddy's Laboratories Limited - Fabbrica Italiana Sintetici - Hospira Inc - Koninklijke DSM N.V. - Lonza Group AG - Lupin Limited - Matrix Laboratories Limited/Mylan Inc - Novartis AG - Novasep Holding - Pfizer Inc - Ranbaxy Laboratories - Sandoz International GmbH - Sigma-Aldrich Corporation - Sun Pharmaceutical Industries Limited - Teva Pharmaceutical Industries Limited - WuXi AppTec, Inc For more information visit http://www.researchandmarkets.com/research/bm...lyzing_the
CBM: 32.96 (+0.09), PFE: 34.64 (-0.23), BMY: 60.04 (+0.56), ALB: 54.59 (+0.63), SIAL: 138.20 (+0.07), TEVA: 56.77 (-0.58), NVS: 102.20 (-0.17)
Active Pharmaceutical Ingredients Global Market - Forecast to 2020
M2 - Tue Aug 26, 10:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n53c3t/active) has announced the addition of the "Active Pharmaceutical Ingredients Global Market - Forecast to 2020" report to their offering. Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source. Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives Overall API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019. The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation. Globally North America accounts the largest share in the API market. Asia-Pacific is second largest followed by Europe. Asia is growing at a highest CAGR compared to North America followed by Europe. The key players of Active Pharmaceutical Ingredient market are Sandoz-Lek-Biochemie (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (India), AstraZeneca plc (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.) and F. Hoffmann-La Roche Ltd. (Switzerland). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Active Pharmaceuticals Ingredients by Synthesis 5. Active Pharmaceuticals Ingredients by Therapeutic Applications 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Albemarle Corporation - Aurobindo - Boehringer Ingelheim GmbH - Cambrex Corporatio - Dr. Reddy's Lab - Lonza Group - Lupin - Novartis - Ranbaxy Laboratories - Teva Active Pharmaceutical Industries Limited For more information visit http://www.researchandmarkets.com/research/n53c3t/active
CBM: 32.96 (+0.09), ALB: 54.59 (+0.63), PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), NVS: 102.20 (-0.17)
Growth Factors (Blood and Tissue) Market 2014 - Global Strategic Business Report
M2 - Thu Aug 14, 2:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bqzzts/growth_factors) has announced the addition of the "Growth Factors (Blood and Tissue) - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) - Tissue Growth Factors. The report profiles 90 companies including many key and niche players such as: - Alseres Pharmaceuticals, Inc. - Amgen, Inc. - Bayer HealthCare Pharmaceuticals, Inc. - Biogen Idec Inc - BioMimetic Therapeutics, Inc. - Biopharm GmbH - Bolder Biotechnology, Inc. - F. Hoffmann-La Roche Ltd - Chugai Pharmaceutical Co. Ltd. - Genentech, Inc. - FibroGen, Inc. - Johnson & Johnson - Janssen Biotech, Inc. - Lonza Group - Merck Serono International S.A. - NsGene A/S - PeproTech, Inc. - Reliance GeneMedix Plc - Sangamo BioSciences, Inc. - Sanofi - Shantha Biotechnics - Scil Proteins GmbH - Wockhardt Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Growth Factors An Overview 3. Research Studies & Clinical Trials 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 90 (including Divisions/Subsidiaries 95) - The United States (42) - Japan (
- Europe (19) - France (1) - Germany ( - The United Kingdom (1) - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (24) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/bq...th_factors JNJ: 99.62 (+1.18), BIIB: 391.66 (-0.45), MRK: 58.81 (-0.07), SGMO: 15.40 (+0.14), AMGN: 153.48 (+0.30)
U.S. Antimicrobial Plastics Market - Industry Analysis 2014 - 2020 (Appliances, Personal Care, Packaging, Automotive, Building & Construction, Healthcare)
M2 - Mon Aug 11, 6:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j6gfj6/u_s) has announced the addition of the "U.S. Antimicrobial Plastics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. Antimicrobial plastics are molded polymers infused with antimicrobials to inhibit the growth of various harmful microorganisms such as fungi and bacteria. Antimicrobial plastics are used in various industries such as healthcare, automotives, building & construction, electronics, packaging and consumer goods. Additionally, they are used in niche applications such as pipes, plastic water storage containers, waste bins and lids. Rising awareness among consumers regarding good health and cleanliness is expected to be one of the primary factors driving the growth of the antimicrobial plastics market. The report on U.S.antimicrobial plastics market report forecasts and analyzes the antimicrobial plastics market on a regional level. The forecast demand on the global level is based on volume (tons) and revenue (USD million) for the period ranging from 2014 to 2020. The study on U.S. antimicrobial plastics market outlines drivers and restraints of the polyester market and their impact on market growth during the mentioned time period. Additionally, the study includes opportunities available for the market on the regional and level and their effect during the said forecast period. All plastics infused with antimicrobials have been classified as antimicrobial plastics under the scope of this study. Personal care includes packaging of personal care products. Packaging of healthcare products has been classified under the packaging segment. Packaging typically includes foods, beverages and pharmaceuticals. In other words, the segment includes all types of packaging, except for personal care products. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Antimicrobial Plastics - Industry Analysis Chapter 4 Antimicrobial Plastics Market - Application Analysis Chapter 5 Company Profiles Companies Mentioned - AkzoNobel N.V. - BASF SE - Bayer AG - Diamond Vogel - E. I. du Pont de Nemours and Company - Ishizuka Glass Co. Ltd. - Lonza Group AG - Momentive Performance Materials Inc. - Sciessent LLC - Sherwin-Williams - Sinanen Zeomic Co Ltd - Teknor Apex - The Dow Chemical Company For more information visit http://www.researchandmarkets.com/research/j6gfj6/u_s
SHW: 285.00 (+1.98)
Global Cell Culture Market 2014-2018: Equipment, Reagent, & Application Breakdown
M2 - Thu Jul 17, 9:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c3qkn9/cell_culture) has announced the addition of the "Cell Culture Market by Equipment, by Reagent, by Application - Global Forecast to 2018" report to their offering. The global cell culture market was valued at an estimated $14,772 million in 2013. This market is expected to grow at a CAGR of 10.71% between 2013 and 2018. Cell culture is the most widely used technique for biopharmaceutical production. A large quantity of cell culture media, sera, and reagents is required for biopharmaceutical production. Biopharmaceutical production is the largest application segment for the cell culture market in 2013. Furthermore, according to IMS Health, biopharmaceutical is expected to be one of the fastest growing pharmaceutical segments by 2017. Growth in the biopharmaceutical industry, aided by strong pipelines for antibiotics and vaccine products will drive the growth of the cell culture market. This report segments the global cell culture market into two market segments, namely, the cell culture equipment and cell culture media, sera, and reagents. The cell culture equipment market is further subsegmented into lab equipment, bio-safety cabinets, consumables, storage equipment, and sterilization equipment. The lab equipment segment is further segmented into cell counters, centrifuges, fermentors and bioreactors, and incubators. The storage equipment segment is further segmented into cryogenic storage and refrigerators and freezers. The cell culture media, sera, and reagents market is subsegmented into serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents. The lab reagents segment is further subsegmented into balanced salt solutions, buffers and chemicals, cell dissociation reagents, and supplements and growth factors. The media segment is further subsegmented into basal media, reduced serum media, and serum-free media. Scope of the Report Cell Culture Equipment Market - Cell Culture Lab Equipment - - Cell Counters - - Fermentors & Bioreactors - - Incubators - - Centrifuge - Cell Culture Bio-safety Cabinets - Cell Culture Consumables - Cell Culture Storage Equipment - - Cell Culture Refrigerators & Freezers - - Cell Culture Cryogenic Storage - Cell Culture Sterilization Equipment Cell Culture Media, Sera, & Reagents Market - Serum - - Fetal Bovine Serum & Other Animal Sera - Media - - Basal Media - - Reduced Serum Media - - Serum-free Media - Lab Reagents for Cell Culture - - Cell Culture Supplements & Growth Factors - - Buffers & Chemicals - - Cell Dissociation Reagents - - Balanced Salt Solutions - Contamination Detection Kits - Cryoprotective Agents - Other Reagents Cell Culture Market, By Application - Biopharmaceutical Production - Tissue Culture & Engineering - Vaccine Production - Drug Screening & Development - Gene Therapy - Toxicity Testing - Cancer Research - Other Applications Companies Mentioned - Becton, Dickinson and Company - Corning, Inc. - Eppendorf AG - Lonza Group Ltd. - Merck Kgaa - Promocell GMBH - Sartorius AG - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/c3...ll_culture
SIAL: 138.20 (+0.07)
